NEONC TECHNOLOGIES HOLDINGS, INC.
Public company- Headquarters
- CALABASAS, California
- Ticker
- NTHI
- CIK
- 0001979414
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class I directorSteven L. Giannotta, M.D. | Oct 15, 2026 | Departed |
| member of the Audit Committee of the BoardNasim Shomali | Aug 21, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive departure
Class I director departs: Steven L. Giannotta, M.D.
Steven L. Giannotta, M.D., Class I director of NEONC TECHNOLOGIES HOLDINGS, INC., resigns the role, effective October 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 15, 2026Role: Class I director
- Executive appointment
Class I director appointed: Ali Mohammad Ahmad Alabedin
Ali Mohammad Ahmad Alabedin was named Class I director of NEONC TECHNOLOGIES HOLDINGS, INC., effective October 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 15, 2026Role: Class I director
- Executive appointment
member of the Audit Committee of the Board appointed: Nasim Shomali
Nasim Shomali was named member of the Audit Committee of the Board of NEONC TECHNOLOGIES HOLDINGS, INC., effective August 18, 2026. The company reported the change in an 8-K/A that cites Item 5.02.
Source: SEC 8-K, filed Aug 21, 2026Role: member of the Audit Committee of the Board
Last verified Nov 8, 2026